Position in ARVN
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$2,987,684
-$204,423 QoQ
Shares Held
281,857
+4.7% QoQ
Ownership
0.431%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WASATCH ADVISORS LP holds $96,311,805 across 9 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TARS |
Tarsus Pharmaceuticals, Inc.
|
368,568 | $23,197,669 | |
| 2 | CCCC |
C4 Therapeutics, Inc.
|
3,522,644 | $16,450,747 | |
| 3 | PHAT |
Phathom Pharmaceuticals, Inc.
|
1,307,247 | $14,183,629 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
312,767 | $12,201,040 | |
| 5 | DYN |
Dyne Therapeutics, Inc.
|
443,668 | $9,853,866 | |
| 6 | MGNX |
Macrogenics Inc
|
2,018,881 | $9,327,230 | |
| 7 | IMTX |
Immatics N.V.
|
441,510 | $4,472,496 | |
| 8 | NKTX |
Nkarta, Inc.
|
1,577,847 | $4,465,307 |
All Filings in ARVN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,987,684 | 281,857 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $3,192,107 | 269,149 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,318,506 | 506,867 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,329,840 | 452,424 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $8,362,739 | 436,241 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $10,737,276 | 435,943 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,332,026 | 275,433 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,562,545 | 207,426 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $9,176,292 | 222,942 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,059,764 | 206,709 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,727,709 | 271,060 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $7,424,647 | 271,766 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,321,677 | 272,484 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,346,019 | 277,501 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,681,658 | 277,540 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $24,396,048 | 362,497 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $31,183,547 | 379,639 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $31,908,192 | 388,272 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $23,229,899 | 301,687 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $17,365,460 | 262,715 | Shares | Sole | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||